Drug intelligence / Profile preview

Lativit

Development stage: Unknown
Lead developer: Green Heart
Modality: Small Molecules
Administration: Oral

Overview

Lativit is an approved oral nutritional supplement syrup marketed by Green Heart for nutritional deficiency and dietary supplementation. It is a multi-ingredient nutraceutical formulation containing lycopene, methylcobalamin, multiple vitamins, and essential minerals, including vitamin A, B-complex vitamins, vitamin C, vitamin E, selenium, zinc, manganese, iodine, and copper. Its therapeutic role is supportive rather than target-specific: it replenishes deficient micronutrients, provides vitamin B12 for nutritional support, and supplies the antioxidant lycopene to help correct deficiencies and support overall nutritional status.

Brand names: Lativit
Other names: Nutritional supplement Lycopene Methylcobalamin Vitamins Minerals

Beyond the preview

Go deeper on Lativit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lativit.

Explore the full profile